Clinical Trial Update: The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in Diabetics [Phase 1, Phase 2]

View source ↗

Summary

A terminated Phase 1/2 clinical trial evaluated the effect of probiotic bacteria on nonalcoholic fatty liver disease in individuals with diabetes; no results ar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Nonalcoholic Fatty Liver Disease

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Fatty Liver, Hepatic Steatosis | Phase 1, Phase 2 | Status: TERMINATED